VT-1598 Inhibits the in vitro Growth of Mucosal Candida Isolates and Protects Against Oropharyngeal Candidiasis in IL-17 Deficient Mice

BACKGROUND: Patients with chronic mucocutaneous candidiasis (CMC) often develop azole-resistant Candida infections, making treatment difficult due to lack of oral antifungal drug options. VT-1598 is a novel broad-spectrum fungal CYP51 inhibitor designed for exquisite selectivity for the fungal targe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Break, Timothy J, Desai, Jigar V, Natarajan, Mukil, Ferre, Elise, Henderson, Christina, Zelazny, Adrian M, Yates, Christopher M, Cohen, Oren J, Schotzinger, Robert J, Garvey, Edward P, Lionakis, Michail
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5632136/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.132
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados